As the year begins to wind down, investors are looking to position themselves for 2026. In recent days, insiders, including beneficial owners, at Crescent Biopharma Inc. ( NASDAQ: CBIO), MGM Resorts International ( NYSE: MGM), and Salesforce Inc. ( NYSE: CRM) have boosted their stakes in their companies in a big way. Though these were the most prominent insider purchases in that time, there were a number of other notable ones as well.
Undoubtedly, it's a historic, unprecedented implosion and one that may very well be exaggerated, given the market's tendency to overswing to the downside. For those seeking deeper value, I continue to find the name intriguing, even as various sell-side analysts continue to turn away from the name. Though it's going to take a lot to turn a corner, I do get why insiders and hedge funds are starting to get aggressive with buying the dip.
A well-known adage reminds us that corporate insiders and 10% owners really only buy shares of a company because they believe the stock price will rise and they want to profit from it. Thus, insider buying can be an encouraging signal for potential investors. This is all the more so during times of uncertainty in the markets, and even when markets are near all-time highs.
A well-known adage reminds us that corporate insiders and 10% owners really only buy shares of a company because they believe the stock price will rise and they want to profit from it. Thus, insider buying can be an encouraging signal for potential investors. This is all the more so during times of uncertainty in the markets, and even when markets are near all-time highs.